Amara, Chandra Sekhar http://orcid.org/0000-0002-8256-7291
Kami Reddy, Karthik Reddy
Yuntao, Yang
Chan, Yuen San
Piyarathna, Danthasinghe Waduge Badrajee
Dobrolecki, Lacey Elizabeth http://orcid.org/0000-0001-6839-629X
Shih, David J. H. http://orcid.org/0000-0002-9802-4937
Shi, Zhongcheng
Xu, Jun
Huang, Shixia
Ellis, Matthew J.
Apolo, Andrea B. http://orcid.org/0000-0001-9409-1836
Ballester, Leomar Y.
Gao, Jianjun http://orcid.org/0000-0001-6138-4472
Hansel, Donna E.
Lotan, Yair http://orcid.org/0000-0001-5692-2723
Hodges, H. Courtney http://orcid.org/0000-0003-4441-497X
Lerner, Seth P. http://orcid.org/0000-0002-6379-2581
Creighton, Chad J. http://orcid.org/0000-0002-6090-703X
Sreekumar, Arun
Zheng, W. Jim http://orcid.org/0000-0001-7411-6047
Msaouel, Pavlos http://orcid.org/0000-0001-6505-8308
Kavuri, Shyam M. http://orcid.org/0000-0002-3321-6727
Putluri, Nagireddy http://orcid.org/0000-0003-4488-7400
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R01 CA282282, R01 CA220297, R01 CA216426)
U.S. Department of Defense (W81XWH-21-1-0613 (CA200996))
Article History
Received: 3 October 2022
Accepted: 12 January 2024
First Online: 14 February 2024
Competing interests
: S.M.K. is stakeholder of NeoZenome Therapeutics Inc. P.M. has received honoraria for service on a Scientific Advisory Board for Mirati Therapeutics, Bristol Myers Squibb, and Exelixis; consulting for Axiom Healthcare Strategies; non-branded educational programs supported by Exelixis and Pfizer; and research funding for clinical trials from Takeda, Bristol Myers Squibb, Mirati Therapeutics, Gateway for Cancer Research, and The University of Texas MD Anderson Cancer Center. M.J.E. reports grants from CPRIT and McNair Medical Foundation during the conduct of the study; personal fees from AstraZeneca outside the submitted work; in addition, M.J.E. has a patent for PAM50 issued, licensed, and with royalties paid from Veracyte. M.J.E. is current employee of AstraZeneca. H.C.H. is a consultant for Avenge Bio, Inc. A.S.K. is Scientific Advisor to Karkinos Health Care Pvt Ltd, India and unpaid visiting faculty to Sri Sathya Sai Institute for Higher Learning, India. The other authors declare that they have no competing interests.